Table 4.
Multiple logistic regression analysis stratified by upper limit of normal ALT levels to examine the odds of HCV patients versus non-HCV controls
| ALT ≦ ULNa (N = 417) | ALT > ULN (N = 532) | |||
|---|---|---|---|---|
| Adjusted OR | 95% CI | Adjusted OR | 95% CI | |
| Age (years) | 0.96* | 0.94–0.99 | 1.01 | 0.99–1.02 |
| Sex (male vs. female) | 0.13* | 0.07–0.27 | 1.08 | 0.71–1.64 |
| Body mass index (kg/m2) | 1.08** | 0.99–1.18 | 1.00 | 0.99–1.01 |
| Total cholesterol (mg/dl) | 1.01* | 1.00–1.02 | 0.99* | 0.98–0.99 |
| Fasting blood glucose (mg/dl) | 1.00 | 0.99–1.01 | 1.01 | 1.00–1.01 |
| Triglyceride (mg/dl) | 1.00 | 1.00–1.00 | 0.99* | 0.99–0.99 |
OR, odds ratio; CI, confidence interval
The models adjusted for age, sex, body mass index, adiponectin, fasting blood glucose, triglyceride, and total cholesterol
aUpper limit of normal (ULN) of serum ALT level is 30 U/l for men and 20 U/l for women
* P < 0.05
** P < 0.1